{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T23:48:31Z","timestamp":1793490511433,"version":"4.5.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T00:00:00Z","timestamp":1603238400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018868","name":"Sphingotec GmbH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018868","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016619","name":"MyoKardia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014588","name":"Sanofi Pasteur","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014588","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014941","name":"Cytokinetics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014941","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015340","name":"Bayer Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015340","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006093","name":"Patient-Centered Outcomes Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006093","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013410","name":"LivaNova","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013410","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Heart Failure"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.jchf.2020.09.013","type":"journal-article","created":{"date-parts":[[2020,11,11]],"date-time":"2020-11-11T20:50:15Z","timestamp":1605127815000},"page":"127-136","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"title":["Atrial Natriuretic Peptide and Treatment With Sacubitril\/Valsartan in Heart\u00a0Failure With Reduced Ejection Fraction"],"prefix":"10.1016","volume":"9","author":[{"given":"Sean P.","family":"Murphy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret F.","family":"Prescott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Camacho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seethalakshmi R.","family":"Iyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan S.","family":"Maisel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. Michael","family":"Felker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javed","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ileana L.","family":"Pi\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasrien E.","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl","family":"Abbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"John C.","family":"Burnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott D.","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James L.","family":"Januzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchf.2020.09.013_bib1","doi-asserted-by":"crossref","first-page":"508","DOI":"10.3181\/00379727-161-40584","article-title":"Heart atria granularity effects of changes in water-electrolyte balance","volume":"161","author":"De Bold","year":"1979","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.jchf.2020.09.013_bib2","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/978-3-540-68964-5_21","article-title":"Modulation of cGMP in heart failure: a new therapeutic paradigm","author":"Boerrigter","year":"2009","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.jchf.2020.09.013_bib3","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2020.09.013_bib4","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.jacc.2017.04.025","volume":"70","author":"Yancy","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2020.09.013_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jama.2019.12821","article-title":"Association of change in N-terminal pro-B-type natriuretic peptide following initiation of sacubitril-valsartan treatment with cardiac structure and function in patients with heart failure with reduced ejection fraction","volume":"322","author":"Januzzi","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.jchf.2020.09.013_bib6","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ahj.2017.12.021","article-title":"Rationale and methods of the Prospective Study of Biomarkers, Symptom Improvement, and Ventricular Remodeling During Sacubitril\/Valsartan Therapy for Heart\u00a0Failure (PROVE-HF)","volume":"199","author":"Januzzi","year":"2018","journal-title":"Am Heart J"},{"key":"10.1016\/j.jchf.2020.09.013_bib7","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1016\/j.jacc.2017.10.036","article-title":"Quality-of-life after everolimus-eluting stents or bypass surgery for left-main disease: results from the EXCEL trial","volume":"70","author":"Baron","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2020.09.013_bib8","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1001\/jamacardio.2019.0179","article-title":"Association of initial and serial C-reactive protein levels with adverse cardiovascular events and death after acute coronary syndrome: a secondary analysis of the VISTA-16 Trial","volume":"4","author":"Mani","year":"2019","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jchf.2020.09.013_bib9","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1016\/j.jacc.2017.09.026","article-title":"Prognostic value of serial ST2 measurements in patients with acute heart failure","volume":"70","author":"van Vark","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2020.09.013_bib10","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.jchf.2019.05.012","article-title":"Differential regulation of ANP and BNP in acute decompensated heart failure: deficiency of ANP","volume":"7","author":"Reginauld","year":"2019","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jchf.2020.09.013_bib11","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1136\/thx.53.12.1059","article-title":"Urinary cGMP concentrations in severe primary pulmonary hypertension","volume":"53","author":"Bogdan","year":"1998","journal-title":"Thorax"},{"key":"10.1016\/j.jchf.2020.09.013_bib12","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.jacc.2018.12.063","article-title":"Effect of neprilysin inhibition on various natriuretic peptide assays","volume":"73","author":"Ibrahim","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2020.09.013_bib13","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/1755-5922.12183","article-title":"Pharmacodynamic and pharmacokinetic profiles of sacubitril\/valsartan (LCZ696) in patients with heart failure and reduced ejection fraction","volume":"34","author":"Kobalava","year":"2016","journal-title":"Cardiovasc Ther"},{"key":"10.1016\/j.jchf.2020.09.013_bib14","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/ejhf.1342","article-title":"Effects of sacubitril\/valsartan on neprilysin targets and the metabolism of natriuretic peptides in chronic heart failure: a mechanistic clinical study","volume":"21","author":"Nougu\u00e9","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2020.09.013_bib15","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.119.006946","article-title":"Reverse cardiac remodeling and outcome after initiation of sacubitril\/valsartan","volume":"13","author":"Januzzi","year":"2020","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jchf.2020.09.013_bib16","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1161\/HYPERTENSIONAHA.110.159210","article-title":"A\u00a0novel atrial natriuretic peptide based therapeutic in experimental angiotensin II mediated acute hypertension","volume":"56","author":"McKie","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.jchf.2020.09.013_bib17","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s11906-011-0244-5","article-title":"M-atrial natriuretic peptide: a novel antihypertensive protein therapy","volume":"14","author":"McKie","year":"2012","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.jchf.2020.09.013_bib18","doi-asserted-by":"crossref","first-page":"e00271","DOI":"10.1128\/MCB.00271-19","article-title":"Functional screening identifies microRNA regulators of corin activity and atrial natriuretic peptide biogenesis","volume":"39","author":"Celik","year":"2019","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jchf.2020.09.013_bib19","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.130978","article-title":"Antisense regulation of atrial natriuretic peptide expression","volume":"4","author":"Celik","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.jchf.2020.09.013_bib20","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/ejhf.799","article-title":"Neprilysin inhibition in heart failure: mechanisms and substrates beyond modulating natriuretic peptides","volume":"19","author":"D\u2019Elia","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2020.09.013_bib21","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1210\/en.2003-1260","article-title":"Inhibitory effect of C-type natriuretic peptide (CNP) on cultured cardiac myocyte hypertrophy: interference between CNP and endothelin-1 signaling pathways","volume":"145","author":"Tokudome","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.jchf.2020.09.013_bib22","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.jacc.2004.10.067","article-title":"C-type natriuretic peptide, a novel antifibrotic and antihypertrophic agent, prevents cardiac remodeling after myocardial infarction","volume":"45","author":"Soeki","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2020.09.013_bib23","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1210\/en.2003-0128","article-title":"Gene expression, secretion, and autocrine action of C-type natriuretic peptide in cultured adult rat cardiac fibroblasts","volume":"144","author":"Horio","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.jchf.2020.09.013_bib24","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1093\/cvr\/cvw184","article-title":"C-type natriuretic peptide and natriuretic peptide receptor B signalling inhibits cardiac sympathetic neurotransmission and autonomic function","volume":"112","author":"Buttgereit","year":"2016","journal-title":"Cardiovasc Res"},{"issue":"Suppl 2","key":"10.1016\/j.jchf.2020.09.013_bib25","first-page":"243S","article-title":"The effect of acute ACE inhibition on atrial natriuretic peptide","volume":"27","author":"Doorenbos","year":"1989","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jchf.2020.09.013_bib26","first-page":"24S","article-title":"Interaction between atrial natriuretic peptide and the renin angiotensin aldosterone system. Endogenous antagonists","volume":"87","author":"Johnston","year":"1989","journal-title":"Am J Med"}],"container-title":["JACC: Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177920305771?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177920305771?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T04:56:51Z","timestamp":1761973011000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213177920305771"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S2213177920305771"],"URL":"https:\/\/doi.org\/10.1016\/j.jchf.2020.09.013","relation":{},"ISSN":["2213-1779"],"issn-type":[{"value":"2213-1779","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Atrial Natriuretic Peptide and Treatment With Sacubitril\/Valsartan in Heart\u00a0Failure With Reduced Ejection Fraction","name":"articletitle","label":"Article Title"},{"value":"JACC: Heart Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchf.2020.09.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}